NCM
VSTM icon

NEXTBio Capital Management’s Verastem VSTM Stock Holding History

NEXTBio Capital Management’s Portfolio VSTM Stock Details VSTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.99M Hold
1,306,800
– – 2.3% 15
2026
Q1 		$6.93M Sell
1,306,800
-530
-0% -$3.27K 3.22% 11
2025
Q4 		$10.1M Buy
+1,307,330
New +$11.7M 5.92% 6

Other funds holding VSTM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

NEXTBio Capital Management's VSTM Position: Q2 2026 in Review

NEXTBio Capital Management held its Verastem (VSTM) position steady in Q2 2026 at 1,306,800 shares worth $4.99M. The position accounts for 2.3% of the portfolio, ranked #15.

NEXTBio Capital Management first reported a position in VSTM in Q4 2025 and has held it in 3 quarters since. The position peaked at $10.1M in Q4 2025. 157 funds tracked by Wall St. Rank hold VSTM as of Q2 2026.

  • NEXTBio Capital Management held 1,306,800 shares of Verastem worth $4.99M as of Q2 2026.
  • NEXTBio Capital Management left its Verastem share count unchanged in Q2 2026.
  • Verastem made up 2.3% of NEXTBio Capital Management's portfolio in Q2 2026, its #15 holding.
  • NEXTBio Capital Management first reported a position in Verastem in Q4 2025 and has held it in 3 quarters since.
  • NEXTBio Capital Management's Verastem position peaked at $10.1M in Q4 2025.
  • 157 funds tracked by Wall St. Rank held Verastem as of Q2 2026.

Based on NEXTBio Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.